Jaguar Health, Inc. (NASDAQ:JAGX) | WebDisclosure

Switch to English

10763	Sociétés
231458	Mots-clés
159848	Articles
123055	Communiqués

Accueil
Sociétés
Jaguar Health, Inc.

COMMUNIQUÉ DE PRESSE

publié le 18/06/2026 à 15:00, il y a 1 mois 4 jours

Magdalena Biosciences, a Joint Venture Between Jaguar Health and Filament Health, Announces Positive Results of Preclinical Study of Coca for Weight Gain Prevention
Magdalena's drug candidate, a coca leaf extract, shows promise for post-GLP-1 weight loss management. Preclinical study results suggest potential as weight maintenance therapy

Preclinical Study Magdalena GLP-1 Therapy Weight Loss Management Coca Leaf Extract
BRÈVE

publiée le 12/06/2026 à 15:05, il y a 1 mois 10 jours

Jaguar Health to Present at Life Sciences Virtual Investor Forum

Crofelemer Jaguar Health Intestinal Failure Life Sciences Forum Pediatric Studies
BRÈVE

publiée le 12/06/2026 à 15:05, il y a 1 mois 10 jours

Jaguar Health présentera ses services lors du Forum virtuel des investisseurs en sciences de la vie

Crofelemer Jaguar Health Insuffisance Intestinale Forum Des Sciences De La Vie Études Pédiatriques
COMMUNIQUÉ DE PRESSE

publié le 12/06/2026 à 15:00, il y a 1 mois 10 jours

Jaguar Health Presenting June 24, 2026 at the Life Sciences Virtual Investor Forum to Provide Updates on Company's Crofelemer Development Program for Rare Intestinal Failure Diseases
Jaguar Health, Inc. announces virtual presentation by CEO Lisa Conte at Life Sciences Virtual Investor Forum on June 24, 2026. Crofelemer presentations at ESPGHAN Meeting

Virtual Presentation Jaguar Health Lisa Conte Life Sciences Forum ESPGHAN Meeting
BRÈVE

publiée le 08/06/2026 à 22:20, il y a 1 mois 14 jours

Jaguar Health Stockholders Approve All Proposals at 2026 Meeting

Jaguar Health Lisa Conte Emerging Growth Conference Annual Meeting Stockholder Proposals
BRÈVE

publiée le 08/06/2026 à 22:20, il y a 1 mois 14 jours

Les actionnaires de Jaguar Health approuvent toutes les propositions lors de l'assemblée générale de 2026.

Jaguar Health Lisa Conte Réunion Annuelle Conférence Sur La Croissance Émergente Propositions Des Actionnaires
COMMUNIQUÉ DE PRESSE

publié le 08/06/2026 à 22:15, il y a 1 mois 14 jours

Jaguar Health Reports Approval of All Proposals at 2026 Annual Meeting of Stockholders
Jaguar Health, Inc. announces approval of proposals at the Annual Meeting of Stockholders. Founder Lisa Conte to present virtually on June 10, 2026 at the Emerging Growth Conference

Virtual Presentation Jaguar Health Lisa Conte Emerging Growth Conference Annual Meeting
BRÈVE

publiée le 28/05/2026 à 16:05, il y a 1 mois 25 jours

Jaguar Health's Ethnobotanical Research Advances Crofelemer Development

Crofelemer Microvillus Inclusion Disease Intestinal Failure Ethnobotanical Medicine Sustainable Harvesting
BRÈVE

publiée le 28/05/2026 à 16:05, il y a 1 mois 25 jours

Les recherches ethnobotaniques de Jaguar Health font progresser le développement du crofelemer

Crofelemer Insuffisance Intestinale Maladie À Inclusions Microvillositaires Médecine Ethnobotanique Récolte Durable
COMMUNIQUÉ DE PRESSE

publié le 28/05/2026 à 16:00, il y a 1 mois 25 jours

Jaguar Health Research in Ethnobotanical Medicine Helps Advance Crofelemer Development for Genetically Defined Rare Congenital Gastrointestinal Disorders
Jaguar Health's crofelemer, an FDA-approved botanical drug derived from Croton lechleri tree, developed as first oral adjunctive therapy for Intestinal Failure (IF) from MVID and SBS, highlighting unique botanical drug platform and indigenous collaboration

Crofelemer Jaguar Health FDA-approved Botanical Drug Intestinal Failure

Les Echos

Publié le 22/07/2026 à 18:19, il y a 18 heures 23 minutes

Covivio place avec succès 500 M€ d’obligations vertes à 7 ans
Publié le 22/07/2026 à 18:19, il y a 18 heures 23 minutes

Covivio successfully places €500 million of 7-year European Green Bonds
Publié le 22/07/2026 à 17:45, il y a 18 heures 57 minutes

Groupe CRIT : 2026 first half revenue: €1.67 billion (+2.3% on an organic basis).
Publié le 22/07/2026 à 17:45, il y a 18 heures 57 minutes

Groupe CRIT : Chiffre d’affaires du 1er semestre 2026 : 1,67 Md€ (+2,3% en organique).
Publié le 22/07/2026 à 17:40, il y a 19 heures 2 minutes

Report on share repurchases from 15 to 21 July 2026

Voir tout LES ECHOS COMFI WIRE

Accesswire

Publié le 23/07/2026 à 12:00, il y a 42 minutes

PJX Resources Completes $6.3m Non-Brokered Private Placement and Commenced Exploration of Critical Metal and Gold Targets in Southeastern British Columbia’s Sullivan Mining District
Publié le 23/07/2026 à 11:30, il y a 1 heure 12 minutes

American Critical Minerals Announces Private Placement in Advance of Its Green River Project Well
Publié le 23/07/2026 à 08:05, il y a 4 heures 37 minutes

Tocvan Discovers New High-Grade At-Surface Silver-Gold Zone 900 m East of Pilot Facility at Gran Pilar Project
Publié le 23/07/2026 à 08:00, il y a 4 heures 42 minutes

Caledonia Mining Corporation Plc: Blanket Exploration Results
Publié le 22/07/2026 à 15:00, il y a 21 heures 42 minutes

Karbon-X Secures Technical Advisory Engagement for Nature-Based Carbon Project in Libya

Voir tout ACCESSWIRE

EQS Group

Publié le 23/07/2026 à 12:24, il y a 17 minutes

Symrise signs a put option agreement to acquire Floral Concept
Publié le 23/07/2026 à 12:17, il y a 25 minutes

EQS-Adhoc: Jungheinrich AG: Jungheinrich revises its forecast for 2026 and announces preliminary figures for the second quarter of 2026
Publié le 23/07/2026 à 12:16, il y a 25 minutes

Correction of a release from 23/07/2026, 08:00 CET/CEST - LPKF Presents Half-Year Financial Report
Publié le 23/07/2026 à 12:05, il y a 37 minutes

Eastern Mediterranean Petrochemical Cluster Developed by Rönesans Attracts Over US$3 Billion in Investment
Publié le 23/07/2026 à 11:15, il y a 1 heure 27 minutes

Amendment Notice - Capital Gearing Trust Plc